• レポートコード:MRC2012A6643 • 出版社/出版日:GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、137ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医薬品、医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、口腔内崩壊錠賦形剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。口腔内崩壊錠賦形剤の種類別市場規模(バインダー、グリデント、希釈剤、崩壊剤、その他)、用途別市場規模(抗精神病薬、抗てんかん薬、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):BASF、Ashland、ABF Ingredients、JRS Pharma、Merck KGaA、Roquette、Shin-Etsu、Evonik、DFE Pharma、Meggle Pharma、Anhui Sunhere Pharmaceutical、Fuji Chemical Industries、Daicel Corporation、McePharma (Vivesa holding)、Cargill Incorporated、 ・地域別グローバル市場分析 2015年-2020年 ・口腔内崩壊錠賦形剤の北米市場(アメリカ、カナダ、メキシコ) ・口腔内崩壊錠賦形剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・口腔内崩壊錠賦形剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・口腔内崩壊錠賦形剤の南米市場(ブラジル、アルゼンチン) ・口腔内崩壊錠賦形剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:バインダー、グリデント、希釈剤、崩壊剤、その他 ・用途別分析:抗精神病薬、抗てんかん薬、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Orally Disintegrating Tablet Excipient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Orally Disintegrating Tablet Excipient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 18460 million by 2025, from USD 16180 million in 2019.
Market segmentation
Orally Disintegrating Tablet Excipient market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Orally Disintegrating Tablet Excipient market has been segmented into
Binders
Glidents
Diluents
Disintegrants
Others
By Application, Orally Disintegrating Tablet Excipient has been segmented into:
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orally Disintegrating Tablet Excipient market presented in the report. This section sheds light on the sales growth of different regional and country-level Orally Disintegrating Tablet Excipient markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orally Disintegrating Tablet Excipient market.
The report offers in-depth assessment of the growth and other aspects of the Orally Disintegrating Tablet Excipient market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Orally Disintegrating Tablet Excipient Market Share Analysis
Orally Disintegrating Tablet Excipient competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orally Disintegrating Tablet Excipient sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orally Disintegrating Tablet Excipient sales, revenue and market share for each player covered in this report.
The major players covered in Orally Disintegrating Tablet Excipient are:
BASF
Ashland
ABF Ingredients
JRS Pharma
Merck KGaA
Roquette
Shin-Etsu
Evonik
DFE Pharma
Meggle Pharma
Anhui Sunhere Pharmaceutical
Fuji Chemical Industries
Daicel Corporation
McePharma (Vivesa holding)
Cargill Incorporated
Among other players domestic and global, Orally Disintegrating Tablet Excipient market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales, revenue and global market share of Orally Disintegrating Tablet Excipient in 2018 and 2019.
Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Orally Disintegrating Tablet Excipient market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Orally Disintegrating Tablet Excipient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orally Disintegrating Tablet Excipient Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Orally Disintegrating Tablet Excipient Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Overview of Global Orally Disintegrating Tablet Excipient Market
1.4.1 Global Orally Disintegrating Tablet Excipient Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BASF
2.1.1 BASF Details
2.1.2 BASF Major Business
2.1.3 BASF SWOT Analysis
2.1.4 BASF Product and Services
2.1.5 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ashland
2.2.1 Ashland Details
2.2.2 Ashland Major Business
2.2.3 Ashland SWOT Analysis
2.2.4 Ashland Product and Services
2.2.5 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 ABF Ingredients
2.3.1 ABF Ingredients Details
2.3.2 ABF Ingredients Major Business
2.3.3 ABF Ingredients SWOT Analysis
2.3.4 ABF Ingredients Product and Services
2.3.5 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 JRS Pharma
2.4.1 JRS Pharma Details
2.4.2 JRS Pharma Major Business
2.4.3 JRS Pharma SWOT Analysis
2.4.4 JRS Pharma Product and Services
2.4.5 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck KGaA
2.5.1 Merck KGaA Details
2.5.2 Merck KGaA Major Business
2.5.3 Merck KGaA SWOT Analysis
2.5.4 Merck KGaA Product and Services
2.5.5 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roquette
2.6.1 Roquette Details
2.6.2 Roquette Major Business
2.6.3 Roquette Product and Services
2.6.4 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shin-Etsu
2.7.1 Shin-Etsu Details
2.7.2 Shin-Etsu Major Business
2.7.3 Shin-Etsu Product and Services
2.7.4 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Evonik
2.8.1 Evonik Details
2.8.2 Evonik Major Business
2.8.3 Evonik Product and Services
2.8.4 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 DFE Pharma
2.9.1 DFE Pharma Details
2.9.2 DFE Pharma Major Business
2.9.3 DFE Pharma Product and Services
2.9.4 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Meggle Pharma
2.10.1 Meggle Pharma Details
2.10.2 Meggle Pharma Major Business
2.10.3 Meggle Pharma Product and Services
2.10.4 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Anhui Sunhere Pharmaceutical
2.11.1 Anhui Sunhere Pharmaceutical Details
2.11.2 Anhui Sunhere Pharmaceutical Major Business
2.11.3 Anhui Sunhere Pharmaceutical Product and Services
2.11.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Fuji Chemical Industries
2.12.1 Fuji Chemical Industries Details
2.12.2 Fuji Chemical Industries Major Business
2.12.3 Fuji Chemical Industries Product and Services
2.12.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daicel Corporation
2.13.1 Daicel Corporation Details
2.13.2 Daicel Corporation Major Business
2.13.3 Daicel Corporation Product and Services
2.13.4 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 McePharma (Vivesa holding)
2.14.1 McePharma (Vivesa holding) Details
2.14.2 McePharma (Vivesa holding) Major Business
2.14.3 McePharma (Vivesa holding) Product and Services
2.14.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Cargill Incorporated
2.15.1 Cargill Incorporated Details
2.15.2 Cargill Incorporated Major Business
2.15.3 Cargill Incorporated Product and Services
2.15.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2019
3.3.2 Top 6 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Regions
4.1.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Regions (2015-2020)
4.1.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Regions (2015-2020)
4.2 North America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
4.3 Europe Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
4.5 South America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
5.1.1 North America Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2015-2020)
5.1.2 North America Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2015-2020)
5.2 United States Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
5.3 Canada Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
5.4 Mexico Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
6.1.1 Europe Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2015-2020)
6.1.2 Europe Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2015-2020)
6.2 Germany Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
6.3 UK Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
6.4 France Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
6.5 Russia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
6.6 Italy Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue and Market Share by Regions (2015-2020)
7.2 China Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7.3 Japan Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7.4 Korea Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7.5 India Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
7.7 Australia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
8.1.1 South America Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2015-2020)
8.1.2 South America Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2015-2020)
8.2 Brazil Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
8.3 Argentina Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
9.3 Turkey Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
9.4 Egypt Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
9.5 South Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Type (2015-2020)
10.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2015-2020)
10.3 Global Orally Disintegrating Tablet Excipient Price by Type (2015-2020)
11 Global Orally Disintegrating Tablet Excipient Market Segment by Application
11.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
11.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2015-2020)
11.3 Global Orally Disintegrating Tablet Excipient Price by Application (2015-2020)
12 Market Forecast
12.1 Global Orally Disintegrating Tablet Excipient Sales, Revenue and Growth Rate (2021-2025)
12.2 Orally Disintegrating Tablet Excipient Market Forecast by Regions (2021-2025)
12.2.1 North America Orally Disintegrating Tablet Excipient Market Forecast (2021-2025)
12.2.2 Europe Orally Disintegrating Tablet Excipient Market Forecast (2021-2025)
12.2.3 Asia-Pacific Orally Disintegrating Tablet Excipient Market Forecast (2021-2025)
12.2.4 South America Orally Disintegrating Tablet Excipient Market Forecast (2021-2025)
12.2.5 Middle East & Africa Orally Disintegrating Tablet Excipient Market Forecast (2021-2025)
12.3 Orally Disintegrating Tablet Excipient Market Forecast by Type (2021-2025)
12.3.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2021-2025)
12.3.2 Global Orally Disintegrating Tablet Excipient Market Share Forecast by Type (2021-2025)
12.4 Orally Disintegrating Tablet Excipient Market Forecast by Application (2021-2025)
12.4.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2021-2025)
12.4.2 Global Orally Disintegrating Tablet Excipient Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Orally Disintegrating Tablet Excipient Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Orally Disintegrating Tablet Excipient Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Orally Disintegrating Tablet Excipient Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. BASF Basic Information, Manufacturing Base and Competitors
Table 9. BASF Orally Disintegrating Tablet Excipient Major Business
Table 10. BASF Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 11. BASF SWOT Analysis
Table 12. BASF Orally Disintegrating Tablet Excipient Product and Services
Table 13. BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Ashland Basic Information, Manufacturing Base and Competitors
Table 15. Ashland Orally Disintegrating Tablet Excipient Major Business
Table 16. Ashland Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 17. Ashland SWOT Analysis
Table 18. Ashland Orally Disintegrating Tablet Excipient Product and Services
Table 19. Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. ABF Ingredients Basic Information, Manufacturing Base and Competitors
Table 21. ABF Ingredients Orally Disintegrating Tablet Excipient Major Business
Table 22. ABF Ingredients Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 23. ABF Ingredients SWOT Analysis
Table 24. ABF Ingredients Orally Disintegrating Tablet Excipient Product and Services
Table 25. ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. JRS Pharma Basic Information, Manufacturing Base and Competitors
Table 27. JRS Pharma Orally Disintegrating Tablet Excipient Major Business
Table 28. JRS Pharma Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 29. JRS Pharma SWOT Analysis
Table 30. JRS Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 31. JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 33. Merck KGaA Orally Disintegrating Tablet Excipient Major Business
Table 34. Merck KGaA Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 35. Merck KGaA SWOT Analysis
Table 36. Merck KGaA Orally Disintegrating Tablet Excipient Product and Services
Table 37. Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Roquette Basic Information, Manufacturing Base and Competitors
Table 39. Roquette Orally Disintegrating Tablet Excipient Major Business
Table 40. Roquette Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 41. Roquette SWOT Analysis
Table 42. Roquette Orally Disintegrating Tablet Excipient Product and Services
Table 43. Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Shin-Etsu Basic Information, Manufacturing Base and Competitors
Table 45. Shin-Etsu Orally Disintegrating Tablet Excipient Major Business
Table 46. Shin-Etsu Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 47. Shin-Etsu SWOT Analysis
Table 48. Shin-Etsu Orally Disintegrating Tablet Excipient Product and Services
Table 49. Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Evonik Basic Information, Manufacturing Base and Competitors
Table 51. Evonik Orally Disintegrating Tablet Excipient Major Business
Table 52. Evonik Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 53. Evonik SWOT Analysis
Table 54. Evonik Orally Disintegrating Tablet Excipient Product and Services
Table 55. Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. DFE Pharma Basic Information, Manufacturing Base and Competitors
Table 57. DFE Pharma Orally Disintegrating Tablet Excipient Major Business
Table 58. DFE Pharma Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 59. DFE Pharma SWOT Analysis
Table 60. DFE Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 61. DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Meggle Pharma Basic Information, Manufacturing Base and Competitors
Table 63. Meggle Pharma Orally Disintegrating Tablet Excipient Major Business
Table 64. Meggle Pharma Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 65. Meggle Pharma SWOT Analysis
Table 66. Meggle Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 67. Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Anhui Sunhere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Major Business
Table 70. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 71. Anhui Sunhere Pharmaceutical SWOT Analysis
Table 72. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Services
Table 73. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Fuji Chemical Industries Basic Information, Manufacturing Base and Competitors
Table 75. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Major Business
Table 76. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 77. Fuji Chemical Industries SWOT Analysis
Table 78. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Services
Table 79. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Daicel Corporation Basic Information, Manufacturing Base and Competitors
Table 81. Daicel Corporation Orally Disintegrating Tablet Excipient Major Business
Table 82. Daicel Corporation Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 83. Daicel Corporation SWOT Analysis
Table 84. Daicel Corporation Orally Disintegrating Tablet Excipient Product and Services
Table 85. Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. McePharma (Vivesa holding) Basic Information, Manufacturing Base and Competitors
Table 87. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Major Business
Table 88. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 89. McePharma (Vivesa holding) SWOT Analysis
Table 90. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Services
Table 91. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Cargill Incorporated Basic Information, Manufacturing Base and Competitors
Table 93. Cargill Incorporated Orally Disintegrating Tablet Excipient Major Business
Table 94. Cargill Incorporated Orally Disintegrating Tablet Excipient Total Revenue (USD Million) (2018-2019)
Table 95. Cargill Incorporated SWOT Analysis
Table 96. Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Services
Table 97. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Global Orally Disintegrating Tablet Excipient Sales by Manufacturer (2018-2019) (K MT)
Table 99. Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2018-2019) (USD Million)
Table 100. Global Orally Disintegrating Tablet Excipient Sales by Regions (2015-2020) (K MT)
Table 101. Global Orally Disintegrating Tablet Excipient Sales Market Share by Regions (2015-2020)
Table 102. Global Orally Disintegrating Tablet Excipient Revenue by Regions (2015-2020) (USD Million)
Table 103. North America Orally Disintegrating Tablet Excipient Sales by Countries (2015-2020) (K MT)
Table 104. North America Orally Disintegrating Tablet Excipient Sales Market Share by Countries (2015-2020)
Table 105. North America Orally Disintegrating Tablet Excipient Revenue by Countries (2015-2020) (USD Million)
Table 106. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020)
Table 107. Europe Orally Disintegrating Tablet Excipient Sales by Countries (2015-2020) (K MT)
Table 108. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Countries (2015-2020)
Table 109. Europe Orally Disintegrating Tablet Excipient Revenue by Countries (2015-2020) (USD Million)
Table 110. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Regions (2015-2020) (K MT)
Table 111. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Regions (2015-2020)
Table 112. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue by Regions (2015-2020) (USD Million)
Table 113. South America Orally Disintegrating Tablet Excipient Sales by Countries (2015-2020) (K MT)
Table 114. South America Orally Disintegrating Tablet Excipient Sales Market Share by Countries (2015-2020)
Table 115. South America Orally Disintegrating Tablet Excipient Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020)
Table 117. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Countries (2015-2020) (K MT)
Table 118. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Countries (2015-2020)
Table 119. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Countries (2015-2020) (USD Million)
Table 120. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020)
Table 121. Global Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 122. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2015-2020)
Table 123. Global Orally Disintegrating Tablet Excipient Revenue by Type (2015-2020) (USD Million)
Table 124. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2015-2020)
Table 125. Global Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 126. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2015-2020)
Table 127. Global Orally Disintegrating Tablet Excipient Sales Forecast by Regions (2021-2025) (K MT)
Table 128. Global Orally Disintegrating Tablet Excipient Market Share Forecast by Regions (2021-2025)
Table 129. Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2021-2025) (K MT)
Table 130. Global Orally Disintegrating Tablet Excipient Market Share Forecast by Type (2021-2025)
Table 131. Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2021-2025)
Table 132. Global Orally Disintegrating Tablet Excipient Market Share Forecast by Application (2021-2025)
Table 133. Direct Channel Pros & Cons
Table 134. Indirect Channel Pros & Cons
Table 135. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Orally Disintegrating Tablet Excipient Picture
Figure 2. Global Sales Market Share of Orally Disintegrating Tablet Excipient by Type in 2019
Figure 3. Binders Picture
Figure 4. Glidents Picture
Figure 5. Diluents Picture
Figure 6. Disintegrants Picture
Figure 7. Others Picture
Figure 8. Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2019
Figure 9. Anti-Psychotics Drug Picture
Figure 10. Anti-Epileptics Drug Picture
Figure 11. Others Picture
Figure 12. Global Orally Disintegrating Tablet Excipient Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Orally Disintegrating Tablet Excipient Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturer in 2019
Figure 33. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Orally Disintegrating Tablet Excipient Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Orally Disintegrating Tablet Excipient Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Regions (2015-2020)
Figure 40. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Regions in 2018
Figure 41. North America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
Figure 42. Europe Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
Figure 44. South America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020)
Figure 46. North America Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Orally Disintegrating Tablet Excipient Sales Market Share by Countries (2015-2020)
Figure 48. North America Orally Disintegrating Tablet Excipient Sales Market Share by Countries in 2018
Figure 49. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Countries in 2018
Figure 51. United States Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Countries in 2019
Figure 57. Germany Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Regions 2019
Figure 65. China Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Orally Disintegrating Tablet Excipient Sales Market Share by Countries in 2019
Figure 72. South America Orally Disintegrating Tablet Excipient Revenue Market Share by Countries in 2019
Figure 73. Brazil Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Orally Disintegrating Tablet Excipient Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Orally Disintegrating Tablet Excipient Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Orally Disintegrating Tablet Excipient Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Orally Disintegrating Tablet Excipient Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Orally Disintegrating Tablet Excipient Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Orally Disintegrating Tablet Excipient Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel